期刊文献+

SLE患者血清DNA水平测定的临床意义 被引量:4

The Measurement of Serum DNA and Its Clinical Significance in Patients with SLE.
暂未订购
导出
摘要 目的检测SLE患者血清DNA含量并探讨其在SLE发病中的作用。方法用荧光分光光度法测定了63例SLE患者。结果SLE患者血清DNA含量明显高于正常人;活动期患者明显高于缓解期患者,但是伴肾功能损害的患者其血清DNA水平普遍较低。血清DNA水平与血沉、ANA呈正相关;与C3、C4呈负相关;与抗dsDNA抗体无相关;与病情积分呈正相关。结论SLE患者存在DNA的代谢异常,血中DNA在SLE的发生发展中起着一定作用,血清DNA含量的测定可做为判断疾病活动的敏感指标。 Objective To measure the content of serum DNA in SLE patients and study the contribution of the abnormality of serum DNA in the development of SLE.Method 63 serum samples of SLE patients were measured by fluorescence spectrophotometer method.Results The content of serum DNA in patients was higher than that in mormal individuals,in patients of active stage was significantly higher than that of resolving stage.The patients with lupus nephritis had a lower serum DNA level compared with non nephritis patients.The serum DNA was positive correlated with ANA,ESR;negative correlated with C 3,C 4. There was no correlation between DNA and anti DNA antibody.In addition,serum DNA concentration was closely positive correlated with the grade of activity of disease.Conclution There was abnormal metabolism of DNA in SLE patients.The DNA in blood circulation plays a important role in the development and progeression of SLE.The serum DNA content can reflect SLE activity more sensitively.
出处 《中国皮肤性病学杂志》 CAS 北大核心 1999年第3期137-139,共3页 The Chinese Journal of Dermatovenereology
关键词 系统性红斑狼疮 DNA 测定 血清 Systemic lupus erythematosus DNA
  • 相关文献

参考文献2

  • 1许蓓红 许德清 等.SLE患者BPMC表面的DNA受体及其临床意义[J].中华皮肤科杂志,1991,24:228-228.
  • 2王丹.循环DNA及其抗体、免疫复合物和与狼疮性肾炎[J].国外医学:泌尿系统分册,1994,14:80-80.

共引文献2

同被引文献17

  • 1丁丛礼,丁赢,刘发,阿斯娅,刘学斌,林志彬,索金良,王格林,邓文龙.抗狼疮散治疗系统性红斑狼疮的临床及实验研究[J].中药药理与临床,1995,11(4):45-49. 被引量:13
  • 2冯学兵,沈南,钱捷,孙莉,华晶,陈顺乐.Single nucleotide polymorphisms of deoxyribonuclease Ⅰand their expre ssion in Chinese systemic lupus erythematosus patients[J].Chinese Medical Journal,2004(11):1670-1676. 被引量:1
  • 3[3]Chitrabamnmg S, Rubm RL, Tan EM. Serum deoxyribonuclease Ⅰ and clinical activity in systanic lupus erythomlRosus [J]. Rhcumato lnt, 1981,1:55 - 60.
  • 4[7]Macanovic M, Lachmann PL. Measurement of deoxyribonuclease Ⅰ (DNase) in the senun and urine of systemic lupus erythematosus(SlE) - prone NZB/NZW mice by a new radial enzyme diffusion assay[J]. Clm Exp Immunol, 1997, 108:220 - 226.
  • 5[8]Napirei M, Karsunky H, et al. Features of systemic lupus erythematosus in Dnasel - deficient mice[J]. Nature Genet, 2000,25:177 - 181.
  • 6[9]Macanovic M, sinicropi D, Shak, et al. the treatment of systemic lupus erythematosus in NZB/NZW hybrid mice, studies with recombinant murine DNase and with dexamethasone[J].Clim Exp Immtmology, 1996,106:243 - 252.
  • 7郭根凯,梁军,侯亚义,李慧,周康新,孙凌云.系统性红斑狼疮患者骨髓间质干细胞对B淋巴细胞免疫抑制作用的初步研究[J].中华风湿病学杂志,2007,11(9):524-527. 被引量:5
  • 8Rumore P M, Steinman C R. Endogenous circulating DNA in systemic lupus erythematosus occurrence as mutimeric complexs bound to histone J Clin Invest. 1990,86:69 - 74.
  • 9Macanovic M, Lachmann P J. Measurement of deoxyribonuclease I(DNase) in the serum and urine of systemic lupus erythematosus(SLE) -prone NZB/NZW mice by a new radial enzyme diffusion assay. Clin Exp Immunol 1997,108:220 - 226.
  • 10Macanovic M, Sinicropi D, Shak S et al. The treatment of systemic lupus erythematosus in NZB/WFI hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunology. 1996, 106:243 -252.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部